RxSight, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-38.9M | $-27.5M | $-48.6M | $-66.8M | $-48.7M | $27.6M |
| Depreciation & Amortization | $3.3M | $3.6M | $4.1M | $3.9M | $4.0M | $3.9M |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $31.6M | $24.6M | $15.7M | $11.4M | $7.6M | $4.2M |
| Net Cash from Operating Activities | $-15.5M | $-16.9M | $-41.6M | $-58.9M | $-44.7M | $-35.2M |
| Investing Activities | ||||||
| Capital Expenditures | $3.8M | $5.4M | $4.8M | $2.4M | $1.9M | $2.5M |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $16.9M | $-99.3M | $-22.1M | $40.0M | $-81.9M | $15.6M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.9M | $123.3M | $61.5M | $6.3M | $137.3M | $25.2M |
| Net Change in Cash | $3.2M | $7.1M | $-2.2M | $-12.6M | $10.7M | $5.6M |
| Free Cash Flow | $-19.3M | $-22.4M | $-46.4M | $-61.2M | $-46.6M | $-37.7M |